Erie Indemnity (ERIE): Evaluating Current Valuation After Recent Share Price Slide

Erie Indemnity (ERIE) shares have been under steady pressure over the past month, shedding 6% and extending their slide to 29% for the year. Investors are weighing the company’s performance and recent fundamentals compared to past years.

See our latest analysis for Erie Indemnity.

This latest pullback in Erie Indemnity’s share price reflects a year where negative momentum has gradually intensified, with investors responding to a combination of cautious outlooks and shifting sentiment. Despite steady revenue and profit growth, the stock’s recent slide has pushed its 1-year total shareholder return to -28.4%. Its 5-year total return remains positive at 36.5%, which highlights that long-term holders have still fared well despite this challenging stretch.

If you’re weighing next moves amid all this volatility, now’s a perfect time to broaden your investing horizons and discover fast growing stocks with high insider ownership

With shares down sharply while Erie Indemnity’s fundamentals remain solid, the real question is whether the recent dip finally signals an undervalued entry point or if the market is rightly bracing for slower future growth.

Price-to-Earnings of 23.6x: Is it justified?

Erie Indemnity is currently trading at a price-to-earnings (P/E) ratio of 23.6x, putting its last close at $292.64. This is notably higher than both industry peers and the estimated fair value level.

The price-to-earnings ratio compares a company’s stock price to its annual earnings per share. For insurers like Erie, the P/E ratio is a key measure of how much investors are willing to pay for a dollar of the firm’s current earnings. A high P/E can point to growth optimism, while a low P/E may suggest skepticism or undervaluation.

In Erie Indemnity’s case, the company’s P/E far exceeds the US insurance industry’s average of 13.2x and the peer average of 14.2x. In addition, the company also trades above its estimated fair P/E of 16.3x, making it stand out as expensive on this metric within its sector.

Explore the SWS fair ratio for Erie Indemnity

Result: Price-to-Earnings of 23.6x (OVERVALUED)

However, slowing revenue growth or unexpected shifts in industry sentiment could challenge the case for Erie Indemnity’s current valuation premium.

Find out about the key risks to this Erie Indemnity narrative.

Another View: The SWS DCF Model Offers a Different Perspective

Looking at the valuation from our DCF model, Erie Indemnity’s current share price appears even more stretched. The SWS DCF model estimates a fair value of $223.12 per share, which is well below the recent market level of $292.64. From this angle, the stock may be more overvalued than the P/E ratio alone suggests.

Look into how the SWS DCF model arrives at its fair value.

Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day (check out Erie Indemnity for example). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 832 undervalued stocks based on their cash flows. If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.

Build Your Own Erie Indemnity Narrative

If you see things differently or want to run your own analysis, you can build your own view in just a few minutes, Do it your way

A good starting point is our analysis highlighting 3 key rewards investors are optimistic about regarding Erie Indemnity.

Looking for more investment ideas?

Don't limit your opportunity set. Take action now and tap into hand-picked investment ideas designed to help you spot the next breakout winner before others do.

• Capture strong yields and consistent income by checking out these 22 dividend stocks with yields > 3% with top payouts above 3%.
• Ride the future of AI-powered healthcare by searching through these 33 healthcare AI stocks and explore companies poised for rapid industry growth.
• Uncover undervalued gems trading below their intrinsic worth with these 832 undervalued stocks based on cash flows and position yourself ahead of the crowd.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com